Professor of Psychiatry, University Pennsylvania

Psychiatry

Jay D. Amsterdam practices Psychiatry. He studied medicine at Jefferson Medical College. Jay D. Amsterdam has written publications. He has 38 publications published with PubMed. The lastest publication is: 'Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.'

Publications

---

• Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.
• Effect of Cognitive Therapy With Antidepressant Medications vs Antidepressants Alone on the Rate of Recovery in Major Depressive Disorder: A Randomized Clinical Trial.
• Rhodiola rosea therapy for major depressive disorder: a study protocol for a randomized, double-blind, placebo- controlled trial.
• Gains in employment status following antidepressant medication or cognitive therapy for depression.
• A randomized placebo controlled trial of rhodiola rosea and sertraline for major depressive disorder.
• The Effect of Postinjury Depression on Quality of Life following Minor Injury.
• Convergence and divergence in the delivery of cognitive therapy in two randomized clinical trials.
• Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy.
• Effectiveness and Mood Conversion Rate of Short-Term Fluoxetine Monotherapy in Patients With Rapid Cycling Bipolar II Depression Versus Patients With Nonrapid Cycling ...
• Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder.
• Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study.
• Greater striatal dopamine transporter density may be associated with major depressive episode.
• The paroxetine 352 bipolar trial: A study in medical ghostwriting.
• Two aspects of the therapeutic alliance: Differential relations with depressive symptom change.
• Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.
• Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode.
• Antidepressant drug effects and depression severity: a patient-level meta-analysis.
• Randomized, double-blind, placebo-controlled trial of Cimicifuga racemosa (black cohosh) in women with anxiety disorder due to menopause.
• A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.
• Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.
• Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
• Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
• Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-r...
• Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study.
• Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression.
• Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
• Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications.
• Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
• Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression.
• 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
• Cognitive therapy vs medications in the treatment of moderate to severe depression.
• Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
• Mood disorders in women from adolescence to late life: an overview.
• A prospective trial of sertraline for chronic subjective dizziness.
• Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
• A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive dis...
• Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients.

Schools

---

• Thomas Jefferson University

• Jefferson Hospital

• Va Hospital University Penn

• University Penn

Doctors Specialties

---

• Psychiatry

Accepted Insurances

---

Education

---

• Thomas Jefferson University
• Jefferson Medical College
• SUNY Upstate Medical University

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Christopher A. Milburn, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles T. McGlynn, MD This Doctor is OpenDoctor Recommended.
	Dr. Emily L. Bray, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarah K. Rosenbaum, MD
	Dr. Anthony Marino Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Jody Whitehouse, MD
	Dr. Sarah G. Demichele, MD This Doctor is OpenDoctor Recommended.
	Dr. Biju B. Basil, MD This Doctor is OpenDoctor Recommended.
	Dr. Michele M. Berlinerblau, MD This Doctor is OpenDoctor Recommended.
	Dr. Maryann Koza, DO
	Dr. Edward P. Phinney, MD This Doctor is OpenDoctor Recommended.
	Dr. Kavita Bharwani, MD This Doctor is OpenDoctor Recommended.
	Dr. Donna M. Sudak, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog